Bullboard - Stock Discussion Forum Poseida Therapeutics Inc PSTX

Healthcare Biotechnology

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. Its pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors, as well as in vivo gene therapy product candidates that address patient populations with high unmet medical... see more

Add To Watchlist

NDAQ:PSTX - Post Discussion

Poseida Therapeutics Inc > Roche Acquires $PSTX in $1.5B Deal, Eyes on $MYNZ

View:

Post by ProfitGrid8448 on Nov 26, 2024 8:21am

Roche Acquires $PSTX in $1.5B Deal, Eyes on $MYNZ

Big news for $PSTX—Roche is acquiring the company in a $1.5B deal, valuing shares at nearly $9 each. A solid premium for investors. With its cutting-edge test developments, $MYNZ could be another candidate for acquisition in the sector. Watching both closely.